Farmakogenetik og skraeddersyet medicinsk behandling

Finn Cilius Nielsen; Niels Borregaard

Farmakogenetik og skraeddersyet medicinsk behandling

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1 Citationer (Scopus)

Abstract

Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.
Udgivelsesdato: 2009-Mar-2

Bidragets oversatte titel	Pharmacogenetics and tailored drug therapy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for læger
Vol/bind	171
Udgave nummer	10
Sider (fra-til)	790-4
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 2009

Bibliografisk note

Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines

Citationsformater

@article{63d2f59009b311df825d000ea68e967b,

title = "Farmakogenetik og skraeddersyet medicinsk behandling",

abstract = "Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2",

author = "Nielsen, {Finn Cilius} and Niels Borregaard",

note = "Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines",

year = "2009",

language = "Dansk",

volume = "171",

pages = "790--4",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "10",

}

TY - JOUR

T1 - Farmakogenetik og skraeddersyet medicinsk behandling

AU - Nielsen, Finn Cilius

AU - Borregaard, Niels

N1 - Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines

PY - 2009

Y1 - 2009

N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

M3 - Tidsskriftartikel

C2 - 19265602

VL - 171

SP - 790

EP - 794

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 10

ER -